FDA Approves Nasal Flu Vaccine for At-Home Use: A Convenient Alternative to Flu Shots

The FluMist vaccine will remain available from prescribers as an in-office treatment.

In a groundbreaking decision, the U.S. Food and Drug Administration (FDA) has approved the use of FluMist, a nasal spray flu vaccine, for administration at home. This marks a significant shift in how people can protect themselves against seasonal influenza, providing a convenient alternative to the traditional flu shot. The new option aims to cater … Read more